ArticleNPJ breast cancer2020

Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.

Kabir A Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.